Skip to main content
Deepak Bhatt, MD, Cardiology, New York, NY

DeepakLBhattMDMPH, MBA

Cardiology New York, NY

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Preventive Cardiology, Vascular Medicine

Director of the Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai in New York City

Dr. Bhatt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bhatt's full profile

Already have an account?

  • Office

    1190 5th Avenue at 101st Street, Box 1030
    New York, NY 10029
    Phone+1 212-241-5174
    Fax+1 212-241-3148

Summary

  • Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, is the Director of the Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai in New York City.


    After graduating as valedictorian from Boston Latin School, Dr. Bhatt obtained his science degree as a National Merit Scholar at MIT. He received his MD from Cornell, an MPH from Harvard, and an Executive MBA from Oxford. He trained in internal medicine at the University of Pennsylvania and in cardiology at Cleveland Clinic. He completed fellowships in interventional cardiology and cerebral and peripheral vascular intervention and served as Chief Interventional Fellow at Cleveland Clinic, where he spent many years as an interventional cardiologist, Associate Professor of Medicine, Director of the Interventional Cardiology Fellowship, Associate Director of the Cardiovascular Medicine Fellowship, and Associate Director of the Cardiovascular Coordinating Center. He then served as the Chief of Cardiology at VA Boston Healthcare System and subsequently as Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital. He was a Senior Investigator in the TIMI Study Group and Editor-in-Chief of the Harvard Heart Letter. He became a full Professor of Medicine at Harvard Medical School in 2012. He was selected by Brigham and Women’s Hospital as the 2014 Eugene Braunwald Scholar. He has been listed in Best Doctors in America from 2005 to 2020. He received the Research Mentor Award from Brigham and Women’s Hospital Department of Medicine in 2016, the Eugene Braunwald Teaching Award for Excellence in the Teaching of Clinical Cardiology from Brigham and Women’s Hospital in 2017, ACC’s Distinguished Mentor Award in 2018, AHA’s Distinguished Scientist Award in 2019, NLA’s Honorary Lifetime Membership Award in 2021, and SCAI’s Master designation in 2022.

Education & Training

  • University of Oxford
    University of OxfordExecutive MBA, 2021 - 2024
  • Harvard School of Public Health
    Harvard School of Public HealthMPH, Clinical Effectiveness, 2007 - 2008
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Interventional Cardiology, 1999 - 2001
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1996 - 1999
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1994 - 1996
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 1993 - 1994
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1993
  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyBS, Science, 1985 - 1989

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2022 - 2026
  • RI State Medical License
    RI State Medical License 2018 - 2026
  • MA State Medical License
    MA State Medical License 2008 - 2025
  • OH State Medical License
    OH State Medical License 2000 - 2025
  • PA State Medical License
    PA State Medical License 1994 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • Master Interventionalist of SCAI (MSCAI) Society for Cardiovascular Angiography and Interventions, 2022
  • Honorary Lifetime Membership Award National Lipid Association, 2021
  • Distinguished Scientist Award American Heart Association, 2019
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients with High-Risk Cardiovascular...  
    Jacob A Udell, Sheila M Hegde, Deepak L Bhatt, J Michael Gaziano, Kristin Nichol, Matthew C Tattersall, Jonathan L Temte, Clyde Yancy, JAMA
  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure  
    Deepak L Bhatt, Darren K Mcguire, Jeffrey M Testani, Pablo Lapuerta, Bertram Pitt, The New England Journal of Medicine
  • Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction with Multivessel Coronary Artery Disea...  
    Eric A Secemsky, Jeptha P Curtis, Salim S Virani, Ehrin J Armstrong, Kendrick A Shunk, Ralph G Brindis, Deepak Bhatt, Robert W Yeh, JAMA Cardiology
  • Join now to see all

Lectures

  • New Opportunities to Improve Management of Patients with or at High Risk of ASCVD Events: You Weigh the Evidence 
  • Double Vs. Triple Therapy Among Patients Needing Oral Anticoagulation and Dual Antiplatelet Therapy: Insights From Clinical Trials 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Reduction in Total Ischemic Events with Icosapent Ethyl in REDUCE-IT 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Join now to see all

Authored Content

  • Revascularization Practices and Outcomes in Patients with Multivessel Coronary Artery Disease Who Presented with Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018August 2020
  • Eagle's Eye View: Your Weekly CV Update from ACC.org (Week of August 17)August 2020
  • Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol GuidelinesAugust 2020
  • Antithrombotic Therapy in Patients with SIHDJuly 2020
  • Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care WorkersJuly 2020
  • Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care WorkersJuly 2020
  • Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients with Acute Ischemic StrokeJune 2020
  • Cost-Effectiveness of Alirocumab in Patients with Acute Coronary Syndromes the ODYSSEY OUTCOMES TrialMay 2020
  • Cost-Effectiveness of Alirocumab in Patients with Acute Coronary Syndromes the ODYSSEY OUTCOMES TrialMay 2020
  • Cost-Effectiveness of Alirocumab in Patients with Acute Coronary Syndromes the ODYSSEY OUTCOMES TrialMay 2020
  • Performance of Hospitals When Assessing Disease-Based Mortality Compared with Procedural Mortality for Patients with Acute Myocardial InfarctionMay 2020
  • Video: Day 3 Highlights | ACC.20/WCC VirtualMarch 2020
  • Eagle's Eye View: Day 3 Highlights | ACC.20/WCC VirtualMarch 2020
  • Video: Day 3 Overview | ACC.20/WCC VirtualMarch 2020
  • Video: Day 3 Highlights | ACC.20/WCC VirtualMarch 2020
  • Video: Day 3 Overview | ACC.20/WCC VirtualMarch 2020
  • Video: Day 2 Highlights | ACC.20/WCC VirtualMarch 2020
  • Video: Day 1 Highlights | ACC.20/WCC VirtualMarch 2020
  • Video: Day 1 Overview | ACC.20/WCC VirtualMarch 2020
  • Aspirin for Primary Prevention of Cardiovascular Disease?February 2019
  • The New Cholesterol Guidelines: What You Need to KnowNovember 2018
  • Aspirin for Primary Prevention of Cardiovascular Disease?September 2018
  • ESC Congress 2018 | Day 4 HighlightsAugust 2018
  • ESC Congress 2018 | Day 2 HighlightsAugust 2018
  • ESC Congress 2018 | Day 1 HighlightsAugust 2018
  • Antithrombotic Therapy for Peripheral Artery Disease Recent AdvancesMay 2018
  • Reply Cardiovascular Risk Models and Statin TherapyMay 2018
  • Lack of Association Between Heart Failure and Incident CancerApril 2018
  • Aortic Valve Replacement in an Era of Rapid Innovation Better the Devil You KnowMarch 2018
  • Long-Term Outcomes of Post-Operative Atrial Fibrillation Guilty as ChargedFebruary 2018
  • Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients with Multivessel Coronary DiseaseJanuary 2018
  • Cardiovascular Risk and Statin Eligibility of Young Adults After an MI Partners YOUNG-MI RegistryJanuary 2018
  • Cardiovascular Risk and Statin Eligibility of Young Adults After an MI Partners YOUNG-MI RegistryJanuary 2018
  • Cardiovascular Risk and Statin Eligibility of Young Adults After an MI Partners YOUNG-MI RegistryJanuary 2018
  • Reply Cost-Effectiveness of Long-Term Ticagrelor in Patients with Prior Myocardial Infarction: Analysis by SubgroupsJanuary 2018
  • 2017 AHA/ACC Clinical Performance and Quality Measures for Adults with ST-Elevation and Non–ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Performance MeasuresOctober 2017
  • Dual Antithrombotic Therapy with Dabigatran After PCI in Atrial FibrillationAugust 2017
  • Join now to see all

Press Mentions

  • ACCEL Lite: Top Takeaways from 2024: Interventional Cardiology with Deepak L. Bhatt, MD, MPH, MBA, FACC
    ACCEL Lite: Top Takeaways from 2024: Interventional Cardiology with Deepak L. Bhatt, MD, MPH, MBA, FACCDecember 3rd, 2024
  • Cardiologist Examines the Latest Breakthroughs in Coronary Inflammation Research
    Cardiologist Examines the Latest Breakthroughs in Coronary Inflammation ResearchNovember 19th, 2024
  • Prolocor Announces Publication of Confirmatory Results from Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
    Prolocor Announces Publication of Confirmatory Results from Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)October 21st, 2024
  • Join now to see all

Committees

  • Member, American College of Cardiology Board of Trustees 2015 - 2018

Professional Memberships